MAPK3 and skin squamous cell carcinoma: In summary, these findings provide evidence for the role of FD in cSCC progression through regulation of ERK1/2 signaling pathway and validate the sensitivity and specificity of danicopan as a potential targeted therapy of advanced cSCC expressing a high level of FD.